The Cetuximab Market, a vital segment within the oncology therapeutics landscape, is experiencing sustained growth, driven by the increasing global prevalence of metastatic colorectal cancer (mCRC) and head and neck cancer (HNC). Cetuximab, a chimeric monoclonal antibody that specifically targets the epidermal growth factor receptor (EGFR), is a cornerstone in the treatment protocol for...
According to a new report from Intel Market Research, the global Durvalumab Market was valued at USD 1.85 billion in 2025 and is projected to grow from USD 2.12 billion in 2026 to USD 4.76 billion by 2034, exhibiting a robust CAGR of 10.6% during the forecast period. Growth is driven by increasing cancer prevalence, advancements in immuno-oncology research, and rising investments in targeted...
Monoclonal Antibody Therapy Market Snapshot
“The global Monoclonal Antibody Therapy Market is expected to reach to USD 482.6 billion by 2032, growing at a CAGR of 12.7% during 2026 to 2032”
Dive into the Monoclonal Antibody Therapy Market report, where you'll find a thorough exploration of the latest market trends, key competitors, and an in-depth competitor analysis. This...
Pemphigus Vulgaris Market Snapshot:
Straits Research has recently added a new report to its vast depository titled Pemphigus Vulgaris Market. The report studies vital factors about the Pemphigus Vulgaris Market that are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share,...
English
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek